STAT1h
Pharmalittle: We’re reading about tariffs’ effect on drug costs, a scrapped vaccine plant expansion, and more
This would reverse progress toward curbing drug shortages. AstraZeneca scrapped plans to invest $558.3 million in its vaccine ...
Sanofi kicks off share buyback plan with $3bn L’Oréal stake purchase
L'Oréal is selling nearly 30 million shares in Sanofi, decreasing its stake in the drugmaker from 9.4% to 7.2%.
Property Week3h
AstraZeneca axes £450m warehouse expansion in battle over government funding
Pharmaceutical giant AstraZeneca has axed plans to invest £450m in expanding its vaccine manufacturing warehouse in Speke, ...
AstraZeneca cancels £450m investment in UK after dispute over Government support
The pharmaceutical giant claimed the Labour Government failed to match its predecessor’s offer of help for the Merseyside investment.
Place North West5h
Rotheram ‘deeply disappointed’ as AZ pulls £450m Speke plan
The current Labour government significantly reduced the offer of state support originally proffered by the Conservatives for the £450m vaccine facility, according to AstraZeneca. A spokesperson for ...
pharmaphorum5h
Report says AZ's UK plant decision is not just about funding
That includes the recent decision to reject NHS use of AZ and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) for HER2-low ...
Demand for action after AstraZeneca scraps £450m Liverpool investment
Liverpool's opposition leader has called for action after AstraZeneca pulled out of plans to build a new £450m facility in ...
pharmaphorum18h
Boost to Enhertu's prospects as FDA clears Roche diagnostic
Roche is the recipient of the new approval, getting the go-ahead from the US regulator for its PATHWAY HER2 (4B5) test to ...